Releases
-
Vanderbilt Divinity School to host screening of ‘Far East Deep South’
Vanderbilt Divinity School will host the third part of a series exploring the realities of the Asian and Asian American diaspora on May 12 the with a 6 p.m. CT film screening and talkback about the documentary film "Far East Deep South." Read MoreMay 12, 2021
-
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read MoreMay 8, 2021
-
Study revises understanding of cancer metabolism
Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. Read MoreMay 8, 2021
-
VUMC to lead national study to treat severe COVID complications
The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19. Read MoreMay 6, 2021
-
Study finds that regulatory protein prevents signaling that triggers cell death
A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered. Read MoreMay 6, 2021
-
New strategy to treat brain bleeding
Vasorelaxing peptides could offer a promising therapeutic strategy for reducing the neurological deficits caused by subarachnoid hemorrhage-induced cerebral blood vessel constriction. Read MoreMay 4, 2021
-
Strength in numbers
Voluntary data sharing across a region’s health systems and ambulatory care practices is important for measuring and improving health care quality and safety, Vanderbilt researchers report. Read MoreMay 3, 2021
-
Vanderbilt researcher explains Pizzly bear hybrid species
Associate Professor of Biological Sciences Larisa DeSantis discusses pizzly bears (grizzy + polar bear hybrid species)! Read MoreApr 20, 2021
-
New therapeutic strategy for leukemia syndrome
Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy. Read MoreApr 20, 2021
-
VUMC aids national effort to repurpose drugs for COVID-19
Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19. Read MoreApr 19, 2021
-
COVID data, by hook or by crook
A switch to paper forms during the COVID-19 pandemic might have hobbled research, but using software with a novel user interface made it possible to accurately extract information from scanned forms. Read MoreApr 19, 2021
-
New insights into kidney development
Integrin-linked kinase, a central component of a complex that coordinates cell signaling involved in migration, proliferation and cell death, plays a role in kidney development and epithelial cell function. Read MoreApr 15, 2021
-
Arrhythmia culprit: supertrafficking ion channel
Charles Sanders, PhD, and colleagues show how a “supertrafficking” mutant potassium channel contributes to heart rhythm abnormalities. Read MoreApr 15, 2021
-
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. Read MoreApr 8, 2021
-
Study revises understanding of cancer metabolism
Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. Read MoreApr 7, 2021
-
Genetic differences in Wilms tumor
Unique somatic gene mutations may contribute to racial disparities in the incidence of Wilms tumor — the most common childhood kidney cancer. Read MoreApr 6, 2021
-
Codeine metabolizer status in clinical practice
Vanderbilt researchers have developed a response score using genetic and clinical information to aid prescribing of the widely used pain medication codeine. Read MoreApr 5, 2021
-
COVID-19 met with intensive teamwork
Team members serving COVID-19 inpatients were more densely connected, interacting far more than their medical ICU counterparts. Read MoreApr 1, 2021
-
Novel way to neutralize Rift Valley Fever Virus
The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development. Read MoreApr 1, 2021
-
Study shows new COVID target could improve vaccines
Despite an impressive vaccination effort that exceeds 2 million shots a day, rates of COVID-19 are again on the rise in several parts of the United States, as is the spread of highly transmissible variants of the virus. Read MoreApr 1, 2021